Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) has recently been introduced as a new surgical technique to increase future liver remnant in patients with marginal liver volume contemplating major liver resection. We herein present two cases. Case 1: a 68-year-old male patient with colorectal liver metastasis was referred to our department. The future liver remnant (FLR) was 22%. We performed first-stage ALPPS and colorectal surgery concurrently and second stage operation was performed 8 days later. The patient discharged 28 days after the first-stage ALPPS procedure. Case 2: a 69-year-old male patient with a huge hepatic mass was referred for hepatic surgery. The FLR was 19%. After the first stage of the ALPPS procedure, acute renal failure and posthepatectomy liver failure occurred. The patient began to recover on the 5th postoperative day. At 10 days after the first stage, the patient completed the second-stage procedure. The patient discharged 23 days after the first-stage ALPPS procedure. So far many studies are currently underway to identify factors associated with the morbidity and mortality of the ALPPS procedure, it is necessary to continue follow-up studies and observe the results. 
INTRODUCTION
Surgical resection is the only treatment for patients with primary or metastatic hepatic malignancies. The treatment is especially recommended in the absence of extrahepatic malignancies. However, this approach is limited by the amount of functional future liver remnant (FLR) after hepatic resection. Surgeons want to preserve adequate FLR to avoid posthepatectomy liver failure. Removal of up to 75% of the total liver volume is feasible in a young patient with normal liver function. In the cases of underlying liver disease, such as chemotherapy-related injury or cirrhosis, an FLR of 40% or greater is required. 1, 2 Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) has been introduced recently, as a new surgical technique to increase FLR in patients with marginal liver volume contemplating major liver resection. 3 The main indication for ALPPS is extensive bilobar colorectal liver metastases with an FLR less than 25%. 4 The researchers hereby report two cases of ALPPS. The first case concerns simultaneous ALPPS and colorectal surgery, for a patient with extensive bilobar colon cancer liver metastases and a small predicted FLR. The second case concerns a patient with a mass larger than 15 centimeters, who underwent an ALPPS procedure.
CASE

Case 1
A healthy and asymptomatic 68-year-old male patient was referred to our institution with synchronous hepatic metastasis of left colon cancer. The initial imaging studies showed seven metastases in the right lobe of liver and two metastases in the left lobe. The largest, which was in segment 6, measured 6.5 cm×5.5 cm×6 cm (Fig. 1 ). The 2). To achieve hepatic clearance, a right hemihepatectomy with partial hepatectomy in left lobe was necessary.
The total liver volume (TLV) was 1,536 ml, the volume of the left lobe, and the FLR volume was 340 ml (22%).
Liver function evaluation revealed albumin 3.9 g/dl, crea- Therefore, the researchers decided to achieve sufficient hypertrophy through ALPPS procedure. Three weeks after the last cycle of chemotherapy, the first stage of ALPPS with left hemicolectomy was performed.
The operation started with a left hemicolectomy for left colon cancer, followed by ALPPS. After identification of the portal structures, the right portal vein was transected.
The right hepatic artery and right hepatic vein were marked with vessel loops. The parenchyma was transected, through a demarcated line, for the right hemiliver and the right border of the middle hepatic vein.
Enucleation was performed for lesions on the left lobe.
Blood loss in the first stage was 650 ml (Figs. 3 and 4 ). Computed tomography volumetry showed that the total liver volume was 2,044 ml and the future liver remnant volume was 385 ml (19% of the total liver volume). The alpha-fetoprotein (AFP) level was 10,264 ng/ml and the prothrombin induced by vitamin K absence-II (PIVKA-II) level was 2,869 mAU/ml. The total liver volume was 2,044 ml, and the FLR volume was 385 ml (19%) (Fig. 7) . Based on these findings, the researchers decided to achieve sufficient hypertrophy through an ALPPS procedure. At nine days postoperatively, an abdominal CT showed significant hypertrophy of the left lateral section (Fig. 8) .
The second operation started with the same abdominal incision and warm saline irrigation. The plastic bag was removed from the right extended lobe of liver. The right hepatic artery was then ligated and divided. The right bile duct and right hepatic vein were divided using vascular staplers. Two silicone drains were placed and the abdomen was closed.
Histopathology confirmed a 17 cm×14 cm×11 cm-sized probably metastatic hepatoid adenocarcinoma, from the stomach and presence of vascular invasion (Fig. 9) . After the second procedure, the patient developed moderate ascites, mild elevation of serum bilirubin (3.51 mg/dl), and mild prolongation of prothrombin time (21.1 sec). The remaining postoperative course was uneventful and the patient was discharged 23 days, after the first procedure.
DISCUSSION
ALPPS has recently been developed to induce rapid liver hypertrophy to reduce posthepatectomy liver failure. In 2012, Schnitzbauer et al. 3 reported that the technique of The use of ALPPS for CRLM is expected to increase.
Since ALPPS surgery for CRLM is performed in patients with no steatosis and no cirrhotic liver, liver hypertrophy and functional recovery after liver resection should be superior to those exhibiting cirrhotic liver. Research to reach consensus on a standardized surgical technique is necessary to improve results, after simultaneous ALPPS and colorectal surgery. Evidence-based criteria are essential to realize the potential advantages of ALPPS without increased morbidity or mortality.
